HAMP and colorectal carcinoma: Notably, hepcidin inhibition increases the response of mice bearing CT26-derived tumors to PD-1 blockers [62], raising the possibility that reducing hepcidin levels in CRC cells increases the immunogenicity of the tumor microenvironment, converting cold tumors to hot tumors.